Company Filing History:
5 out of 5 
2 out of 41,572 
Years Active: 2016-2025
Title: Wei Zheng: Innovator in Pharmaceutical Development
Introduction
Wei Zheng is a prominent inventor based in San Diego, CA, known for his contributions to pharmaceutical innovations. He holds a total of 7 patents, showcasing his expertise in developing novel therapeutic solutions.
Latest Patents
Among his latest patents is the "Addition salt of S1P1 receptor agonist and crystal form thereof." This patent discloses a salt form and a crystal form of a drug targeting S1P1 receptor-mediated diseases. The compound, 1-{2-fluoro-4-[5-(4-isobutylphenyl)-1,2,4-oxadiazole-3-yl]benzyl}-3-azetidinecarboxylic acid, is designed to treat and prevent symptoms associated with these diseases. Another significant patent is for an "Antibody for binding to interleukin 4 receptor." This invention includes an antibody capable of binding to the IL-4 receptor, along with a nucleic acid sequence encoding the antibody and methods for its production and medical use.
Career Highlights
Wei Zheng has worked with notable companies such as Suzhou Connect Biopharmaceuticals and Qualcomm Incorporated. His experience in these organizations has contributed to his innovative work in the pharmaceutical field.
Collaborations
Wei has collaborated with talented individuals, including Wubin Pan and Xin Yang, enhancing his research and development efforts.
Conclusion
Wei Zheng's contributions to pharmaceutical innovations and his impressive portfolio of patents highlight his significant role in advancing medical science. His work continues to impact the field positively.